Art

J-GLOBAL ID：200902246202956794   Reference number：08A0285623

FURTHER DEVELOPMENTS REGARDING CHEMOTHERAPY FOR THE TREATMENT OF UROTHELIAL CANCER

化学療法の新たな展開

Author (1)： TANJI NOZOMU (愛媛大 大学院医学系研究科 泌尿器制御学分野)
Material： 西日本泌尿器科  (Nishinihon Journal of Urology)
Volume： 70  Issue： 3  Page： 132-136  Publication year： Mar. 20, 2008 
JST Material Number： Z0253B  ISSN： 0029-0726  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *drug therapy ,...
Semi thesaurus term： cisplatin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0285623&from=J-GLOBAL&jstjournalNo=Z0253B") }}

JST classification (2)： Urogenital tumors(=neoplasms)  (GM04000S) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (1)： Gemcitabine

Reference (19)：

• STERNBERG, C. N. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer. 1989, 64, 2448-2458
• LOEHRER, P. J. Sr. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma : a cooperative group study. J. Clin. Oncol. 1992, 10, 1066-1073
• SAXMAN, S. B. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma : a cooperative group study. J. Clin. Oncol. 1997, 15, 2564-2569
• BAJORIN, D. F. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J. Clin. Oncol. 1999, 17, 3173-3181
• LOGOTHETIS, C. J. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J. Clin. Oncol. 1990, 8, 1050-1055

Terms in the title (2)： 化学療法 ,  展開